The results showed that elevated IL-17 expression was observed in the patients with LNM, a low degree of differentiation, late overall TNM stage, and advanced T3/T4 stage, while no significant associations of IL-17 expression were found to be correlated with patient age, gender, and tumor sites (all P > 0.05) (Table 2). Here, IL17A is linked to neoplasm.